Article

Quantitative cancer-immunity cycle modeling for predicting disease progression in advanced metastatic colorectal cancer

2024-05-03

Abstract excerpt

Patients diagnosed with advanced metastatic colorectal cancer (mCRC) often exhibit heterogeneous disease progression and face poor survival prospects. In order to comprehensively analyze the varied treatment responses among individuals and the challenge of tumor recurrence resistant to drugs in advanced mRCR, we developed a novel quantitative cancer-immunity cycle (QCIC) model. The proposed model was meticulously...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4df89ce0-7781-546c-a812-6b7402866e56
DOI: 10.1101/2024.04.30.591845

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Quantitative cancer-immunity cycle modeling for predicting disease progression in advanced metastatic colorectal cancerDOI 10.1101/2024.04.30.591845Read

Longitudinal analysis of peripheral blood immune status and prognosis dynamic prediction for advanced colon cancer with first-line chemotherapySemantic proximity Read

Modular mechanistic mathematical models for improved biomarker identification and treatment scheduling in oncologySemantic proximity Read

Mathematical Model Predicts Tumor Control Patterns Induced by Fast and Slow CTL Killing MechanismsSemantic proximity Read

Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibitionSemantic proximity Read

A multiscale model of immune surveillance in micrometastases: towards cancer patient digital twinsSemantic proximity Read

Optimized patient-specific immune checkpoint inhibitors therapy for cancer treatment based on tumor immune microenvironment modelingSemantic proximity Read

Dissecting T-cell exhaustion heterogeneity and immune ecosystem dynamics in colorectal cancer through multi-omics machine learningSemantic proximity Read

High-Throughput Screening of Combinatorial Immunotherapies with Patient-Specific In Silico Models of Metastatic Colorectal CancerSemantic proximity Read

Immunogram defines four cancer-immunity cycle phenotypes with distinct clonal selection patterns across solid tumors.Semantic proximity Read

An in silico exploration of combining Interleukin-12 with Oxaliplatin to treat liver-metastatic colorectal cancerSemantic proximity Read

Personalized Immunotherapy via Multiscale Tumor-Immune Modeling and Optimal ControlSemantic proximity Read

Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patientsSemantic proximity Read